IRS Deliberation on AbbVie Tax Court Ruling May Reshape U.S. Pharmaceutical Sector’s Global Tax Strategy
The competitive landscape of the U.S. pharmaceutical industry may soon witness a significant shift if the Internal Revenue Service (IRS) decides to align with a decision by the U.S. Tax Court concerning AbbVie Inc. The court recently sided with AbbVie in a dispute over the allocation of income between the company and its foreign subsidiaries….